Low-Dose Weekly vs High-Dose Cisplatin

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
Locally Advanced Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

High-Dose Cisplatin

Intravenous administration of High-Dose Cisplatin

DRUG

Low-Dose Cisplatin

Intravenous administration of Low-Dose Cisplatin

RADIATION

Radiotherapy

Participating centres are to follow their local radiation treatment planning and delivery techniques.

Trial Locations (3)

L8N 3Z5

RECRUITING

Juravinski Cancer Centre, Hamilton

N6A 5W9

ACTIVE_NOT_RECRUITING

London Regional Cancer Program, London

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER